-
2024-511650-50-00
5
2025-01-17
METASTATIC CASTRATION RESISTANT PROSTATE CANCER
-
2024-514228-18-00
4
2025-01-16
Asthma in adults who remain uncontrolled despite medium to high dose I
-
2024-510730-40-00
5
2024-12-12
Hidradenitis Suppurativa
-
2023-510487-12-00
4
2024-11-29
Crohn's Disease
-
2023-504040-34-01
5
2024-11-12
Crohn’s Disease
-
2023-509302-30-00
5
2024-11-04
Hypertriglyceridemia
-
2023-509300-14-00
5
2024-10-31
Severe hypertriglyceridemia (SHTG)
-
2024-511213-38-00
4
2024-10-15
Coeliac disease
-
2023-506769-67-00
4
2024-09-04
Moderate to Severely Active Ulcerative Colitis
-
2022-502518-98-00
5
2024-04-26
nonsegmental vitiligo
-
2022-502442-27-00
5
2024-01-08
Obesity
-
2023-503655-10-00
5
2023-11-20
Systemic Lupus Erythematosus (SLE).
-
2022-502966-26-01
5
2023-10-27
Sjögren’s syndrome
-
2022-502779-40-00
5
2023-09-04
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
-
2022-501419-15-00
5
2023-08-23
Atrial Fibrillation
-
2022-501176-26-00
5
2023-08-04
Acute Ischemic Stroke and High-Risk Transient Ischemic Attack
-
2022-501999-26-00
5
2023-07-12
Severe Hypertriglyceridemia (SHTG)
-
2024-515027-11-00
4
2023-06-29
Crohn’s disease
-
2024-517901-97-00
4
2023-06-13
Localized or a locally advanced high-risk prostate cancer
-
2022-500290-14-01
4
2023-05-11
Colitis ulcerative
-
2022-501608-85-00
5
2023-05-09
Cardiovascular disease (atherosclerotic cardiovascular disease (ASCVD)
-
2022-501939-16-00
5
2023-05-09
Heart failure (HF) with mildly reduced ejection fraction (HFmrEF) or H
-
2024-513462-19-00
5
2023-03-30
Refractory Chronic Cough, Including Unexplained Chronic Cough
-
2022-500953-17-00
4
2023-03-23
Moderately to severely active ulcerative colitis